Mehra Uneek bought BBOT
August 26, 2025 · Form 4 insider transaction
Mehra Uneek bought 633,570 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
633,570
Price
$0.00
Total value
N/A
InsiderMehra Uneek
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 26, 2025
Filing dateAugust 28, 2025
Shares owned after633,570
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying such option shall vest on July 21, 2026, with the remainder vesting in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service the Issuer on each such vesting date.